Hansa Biopharma AB (publ)

LSE:0RC7 Stock Report

Market Cap: SEK 2.5b

Hansa Biopharma AB (publ) Company Information

Hansa Biopharma AB (publ)'s employee growth, exchange listings and data sources


Key Information

  • Name: Hansa Biopharma AB (publ)
  • Ticker: 0RC7
  • Exchange: LSE
  • Founded: 2007
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: SEK 2.543b
  • Shares Outstanding: 67.81m
  • Website: https://www.hansabiopharma.com

Number of Employees


Location

  • Hansa Biopharma AB (publ)
  • ScheelevAegen 22
  • Lund
  • Skåne County
  • 223 63
  • Sweden


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
HNSAOM (OMX Nordic Exchange Stockholm)YesClass A SharesSESEKOct 2007
HNSB.FOTCPK (Pink Sheets LLC)YesClass A SharesUSUSDOct 2007
0RC7LSE (London Stock Exchange)YesClass A SharesGBSEKOct 2007
24HDB (Deutsche Boerse AG)YesClass A SharesDEEUROct 2007
HNSASBATS-CHIXE (BATS 'Chi-X Europe')YesClass A SharesGBSEKOct 2007

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/12/26 18:16
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 18:16
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hansa Biopharma AB (publ) is covered by 14 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Christian LeeABG Sundal Collier Sponsored
Madhu KumarB. Riley Securities, Inc.